LiveRamp Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LiveRamp Holdings, Inc. on February 12, 2026. The filing primarily addresses a significant amendment to the Company's existing share repurchase program approved by the Board of Directors on the same date.
Key Financial Metrics and Capital Allocation
- Share Repurchase Authorization: The Board authorized an additional $200 million in repurchases.
- Total Program Capacity: The total amount authorized for repurchase is now $1.5 billion.
- Utilization: Prior to this increase, the Company had utilized $1.163 billion.
- Remaining Capacity: Following the amendment, the Company has $337 million in remaining capacity under the program.
- Program Duration: The program has been extended through December 31, 2027.
Note: This filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the reporting period.
Material Changes
The primary material change is the expansion of the share repurchase program. The authorization increase of $200 million raises the total program size from $1.3 billion to $1.5 billion and extends the expiration date to December 31, 2027. The Company previously had $137 million in remaining capacity before this amendment.
Outlook, Risks, and Management Commentary
Management indicated that shares may be purchased in open market transactions or pursuant to Rule 10b5-1 trading plans. The timing, manner, price, and amount of repurchases are at the Company's discretion, and the program may be suspended, terminated, or modified at any time. The filing includes standard forward-looking statement disclaimers regarding market price fluctuations, operating results, and financial condition.
Key Facts for Investor Verification
- Verify the total remaining repurchase capacity of $337 million against recent trading volumes.
- Confirm the new expiration date of the repurchase program (December 31, 2027).
- Review the Company's most recent 10-Q or 10-K for current cash balances to assess liquidity relative to the $1.5 billion total authorization.
- Monitor future 10-Q filings for actual repurchase activity and remaining capacity updates.